← All Pillars
Clinical-Stage Decision Making
The board's role in the decisions that define clinical-stage companies
Clinical-Stage Decision Making10 min read
How Boards Should Evaluate Ambiguous Clinical Data
When the clinical results are not clearly positive or clearly negative, the board faces its hardest test. A practical framework for navigating the gray zone.
|Lawrence Fine
Clinical-Stage Decision Making8 min read
The Board's Role in Trial Go/No-Go Decisions
The most consequential decision a clinical-stage biopharma board makes is whether to advance a program to the next trial phase. Most boards get the process wrong.
|Lawrence Fine
Clinical-Stage Decision Making9 min read
Governance vs. Management in Clinical Development
Where the board's oversight role ends and the management team's execution authority begins — and why getting this boundary wrong is the most common governance failure in biopharma.
|Lawrence Fine